Thyroid Dysfunction among Greek Patients with Type 1 and Type 2 Diabetes Mellitus as a Disregarded Comorbidity

Introduction. The aim of this study was to determine the prevalence of thyroid dysfunction in Greek patients with type 1 (T1DM) and type 2 (T2DM) diabetes mellitus as well as its possible relations to glycaemic control and to diabetic complications. Methods. A total of 1015 patients, consecutively f...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria E. Barmpari, Maria Kokkorou, Anastasia Micheli, Irene Alexiou, Elefteria Spanou, Marina Noutsou, Anastasia Thanopoulou
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2017/6505814
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849473454546354176
author Maria E. Barmpari
Maria Kokkorou
Anastasia Micheli
Irene Alexiou
Elefteria Spanou
Marina Noutsou
Anastasia Thanopoulou
author_facet Maria E. Barmpari
Maria Kokkorou
Anastasia Micheli
Irene Alexiou
Elefteria Spanou
Marina Noutsou
Anastasia Thanopoulou
author_sort Maria E. Barmpari
collection DOAJ
description Introduction. The aim of this study was to determine the prevalence of thyroid dysfunction in Greek patients with type 1 (T1DM) and type 2 (T2DM) diabetes mellitus as well as its possible relations to glycaemic control and to diabetic complications. Methods. A total of 1015 patients, consecutively followed in the Outpatient Diabetes Center, were studied. Anthropometric and biochemical measurements, occurrence of diabetes complications, and classical comorbidities were assessed. Average HbA1c of the previous year was calculated. Wellbeing was determined, using a 10-point optimal scale. All the above parameters were compared between subjects with or without thyroid disease. Results. All patients were euthyroid at the time of the study, either on thyroid medications or not. Hypothyroidism occurrence did not differ between T2DM and T1DM patients (37.1% versus 43.5%, p>0.05). Nodular goiter was observed more frequently in T2DM patients (34.1% versus 18.8%, p<0.05). T2DM patients with hypothyroidism compared to those without hypothyroidism had higher HbA1c (7.27% versus 6.98%, p<0.01), TChol (184.97 mg/dl versus 168.17 mg/dl, p<0.001), and higher HDL-Chol (51.28 mg/dl versus 46.77 mg/dl, p<0.01). T2DM patients without hypothyroidism had a better wellness feeling (7.5 versus 5.3 points, p<0.01). Conclusions. Screening for thyroid disease among T2DM patients should be routinely considered, as it is found to be an additional commorbidity. If it remains undiagnosed, it could aggravate the clinical course of the disease.
format Article
id doaj-art-d237da396cf64f1f95db27976877405a
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-d237da396cf64f1f95db27976877405a2025-08-20T03:24:07ZengWileyJournal of Diabetes Research2314-67452314-67532017-01-01201710.1155/2017/65058146505814Thyroid Dysfunction among Greek Patients with Type 1 and Type 2 Diabetes Mellitus as a Disregarded ComorbidityMaria E. Barmpari0Maria Kokkorou1Anastasia Micheli2Irene Alexiou3Elefteria Spanou4Marina Noutsou5Anastasia Thanopoulou6Diabetes Center, 2nd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital of Athens, Athens, GreeceDiabetes Center, 2nd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital of Athens, Athens, GreeceDiabetes Center, 2nd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital of Athens, Athens, GreeceDiabetes Center, 2nd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital of Athens, Athens, GreeceDiabetes Center, 2nd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital of Athens, Athens, GreeceDiabetes Center, 2nd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital of Athens, Athens, GreeceDiabetes Center, 2nd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital of Athens, Athens, GreeceIntroduction. The aim of this study was to determine the prevalence of thyroid dysfunction in Greek patients with type 1 (T1DM) and type 2 (T2DM) diabetes mellitus as well as its possible relations to glycaemic control and to diabetic complications. Methods. A total of 1015 patients, consecutively followed in the Outpatient Diabetes Center, were studied. Anthropometric and biochemical measurements, occurrence of diabetes complications, and classical comorbidities were assessed. Average HbA1c of the previous year was calculated. Wellbeing was determined, using a 10-point optimal scale. All the above parameters were compared between subjects with or without thyroid disease. Results. All patients were euthyroid at the time of the study, either on thyroid medications or not. Hypothyroidism occurrence did not differ between T2DM and T1DM patients (37.1% versus 43.5%, p>0.05). Nodular goiter was observed more frequently in T2DM patients (34.1% versus 18.8%, p<0.05). T2DM patients with hypothyroidism compared to those without hypothyroidism had higher HbA1c (7.27% versus 6.98%, p<0.01), TChol (184.97 mg/dl versus 168.17 mg/dl, p<0.001), and higher HDL-Chol (51.28 mg/dl versus 46.77 mg/dl, p<0.01). T2DM patients without hypothyroidism had a better wellness feeling (7.5 versus 5.3 points, p<0.01). Conclusions. Screening for thyroid disease among T2DM patients should be routinely considered, as it is found to be an additional commorbidity. If it remains undiagnosed, it could aggravate the clinical course of the disease.http://dx.doi.org/10.1155/2017/6505814
spellingShingle Maria E. Barmpari
Maria Kokkorou
Anastasia Micheli
Irene Alexiou
Elefteria Spanou
Marina Noutsou
Anastasia Thanopoulou
Thyroid Dysfunction among Greek Patients with Type 1 and Type 2 Diabetes Mellitus as a Disregarded Comorbidity
Journal of Diabetes Research
title Thyroid Dysfunction among Greek Patients with Type 1 and Type 2 Diabetes Mellitus as a Disregarded Comorbidity
title_full Thyroid Dysfunction among Greek Patients with Type 1 and Type 2 Diabetes Mellitus as a Disregarded Comorbidity
title_fullStr Thyroid Dysfunction among Greek Patients with Type 1 and Type 2 Diabetes Mellitus as a Disregarded Comorbidity
title_full_unstemmed Thyroid Dysfunction among Greek Patients with Type 1 and Type 2 Diabetes Mellitus as a Disregarded Comorbidity
title_short Thyroid Dysfunction among Greek Patients with Type 1 and Type 2 Diabetes Mellitus as a Disregarded Comorbidity
title_sort thyroid dysfunction among greek patients with type 1 and type 2 diabetes mellitus as a disregarded comorbidity
url http://dx.doi.org/10.1155/2017/6505814
work_keys_str_mv AT mariaebarmpari thyroiddysfunctionamonggreekpatientswithtype1andtype2diabetesmellitusasadisregardedcomorbidity
AT mariakokkorou thyroiddysfunctionamonggreekpatientswithtype1andtype2diabetesmellitusasadisregardedcomorbidity
AT anastasiamicheli thyroiddysfunctionamonggreekpatientswithtype1andtype2diabetesmellitusasadisregardedcomorbidity
AT irenealexiou thyroiddysfunctionamonggreekpatientswithtype1andtype2diabetesmellitusasadisregardedcomorbidity
AT elefteriaspanou thyroiddysfunctionamonggreekpatientswithtype1andtype2diabetesmellitusasadisregardedcomorbidity
AT marinanoutsou thyroiddysfunctionamonggreekpatientswithtype1andtype2diabetesmellitusasadisregardedcomorbidity
AT anastasiathanopoulou thyroiddysfunctionamonggreekpatientswithtype1andtype2diabetesmellitusasadisregardedcomorbidity